Abiraterone Acetate FDA approval date

The FDA approved Abiraterone Acetate (Zytiga) on 28 Apr 2011.

FDA approval date
28 Apr 2011

Drug identity checked against registry records

Also recorded as Abiraterone; Zytiga

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117ExelixisPhase 3Active not recruiting2024-04-19Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2011-04-28DayAbiraterone AcetateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202379", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["ZYTIGA"], "active_ingredients": ["ABIRATERONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110428", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026